Is there enough evidence to support sacral neuromodulation as a viable treatment option in children and adolescents with neurogenic lower urinary tract dysfunction?
Crossref DOI link: https://doi.org/10.1007/s00345-019-02832-5
Published Online: 2019-06-03
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Apostolidis, Apostolos
Text and Data Mining valid from 2019-06-03
Version of Record valid from 2019-06-03
Article History
Received: 27 May 2019
Accepted: 29 May 2019
First Online: 3 June 2019